top of page
Search
Doug Bright
Oct 9, 2023
Radiopharm Theranostics green-lighted for radioactive lung cancer trial
The Human Research Ethics Committee (HREC) has given Radiopharm Theranostics its stamp of approval to begin first-in-human phase-one dose...
Steve Butler
Aug 24, 2023
Radiopharm inks new deal in fight against prostate cancer
Radiopharm Theranostics has negotiated an expanded agreement with TerThera for the supply of the terbium-161 (Tb-161) isotope to continue...
Michael Philipps
May 29, 2023
Radiopharm gets big boost for brain cancer trials bid
A positive meeting with the United States Food and Drug Administration (USFDA) has boosted Radiopharm Theranostics’ approval prospects...
Michael Philipps
May 9, 2023
Radiopharm Theranostics secures US approval for second cancer treatment
A pancreatic cancer treatment developed by ASX-listed Radiopharm Theranostics has been granted crucial orphan drug designation by the...
bottom of page